Skip to main content
. 2020 Nov 17;113(6):699–709. doi: 10.1093/jnci/djaa163

Table 6.

Borderline ovarian tumor risk according to fertility treatment characteristics, excluding the first year of follow-up

Fertility treatment characteristics No. of ovarian tumors No. of women Adj. HR (95% CI)a
ART exposure
 Non-ART 17 9972 1 (Referent)
 ART 79 30 565 1.84 (1.08 to 3.14)
Total No. of ART cycles
 0 17 9972 1 (Referent)
 1-2 30 12 485 1.84 (1.00 to 3.37)
 3-4 33 11 587 2.04 (1.12 to 3.71)
 ≥5 16 6493 1.55 (0.78 to 3.09)
Total No. of IUI and ART cyclesb
 0 11 4574 1 (Referent)
 1-2 25 9047 1.62 (0.79 to 3.32)
 3-4 27 8688 1.69 (0.83 to 3.45)
 5-6 11 4515 1.34 (0.58 to 3.12)
 ≥7 15 8446 1.07 (0.48 to 2.37)
 Missing 7 5267 0.62 (0.24 to 1.61)
Response at 1st ART cyclec,d
 Normal response 38 14 943 1 (Referent)
 Poor response 14 4340 1.13 (0.61 to 2.09)
 Missing 27 11 282 1.09 (0.66 to 1.79)
Clomiphene used
 Never 28 9712 1 (Referent)
 Ever 13 6515 0.62 (0.32 to 1.20)
 Missing 38 14 338 0.80 (0.49 to 1.30)
Main subfertility diagnosise
 Male factor 18 11 572 1 (Referent)
 Tubal factor 51 12 952 2.47 (1.44 to 4.25)
 Unexplained or other factor 27 16 013 1.07 (0.59 to 1.95)
Endometriosise,f
 No 83 36 936 1 (Referent)
 Yes 13 3601 1.33 (0.74 to 2.40)
Paritye
 Nulliparous 40 13 295 1 (Referent)
 Parous 56 26 988 0.76 (0.51 to 1.15)
a

Analyses include 40 537 women, 30 565 ART-treated women, and 9972 non-ART–treated women. Each variable was analyzed in a separate model. All analyses are adjusted for age at start treatment or first visit to gynecologist, parity, and tubal subfertility. Adj. HR = adjusted hazard ratio; ART = assisted reproductive technology; CI = confidence interval; IUI = intrauterine insemination.

b

Includes stimulated and nonstimulated IUI cycles. Based on information from medical records if available and on information from questionnaires if no medical record information was available. Women with missing data about IUI cycles and with a tubal cause of subfertility were categorized in the 0 IUI cycles category.

c

Poor response includes canceled first cycles because of anticipated poor response and less than 4 oocytes; normal response includes 4 or more oocytes collected in first cycle. Too few women with ovarian hyperstimulation syndrome to perform analysis.

d

Among 30 565 ART-treated women only; 79 borderline ovarian tumor cases.

e

Additionally adjusted for ART exposure (yes/no), not adjusted for tubal subfertility.

f

Histologically proven endometriosis, based on information from the Nationwide Network and Registry of Histo- and Cytopathology in the Netherlands (PALGA).